How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/naproxen-sodium-codeine.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Naproxen Sodium Codeine — Competitive Intelligence Brief

Naproxen Sodium Codeine (Naproxen Sodium Codeine) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: NSAID + opioid combination analgesic. Area: Pain Management.

marketed NSAID + opioid combination analgesic COX-1/COX-2 enzymes; mu opioid receptor Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Naproxen Sodium Codeine (Naproxen Sodium Codeine) — Istanbul Medeniyet University. Naproxen sodium inhibits cyclooxygenase (COX) enzymes to reduce inflammation and pain, while codeine acts as an opioid agonist to provide additional analgesic and antitussive effects.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Naproxen Sodium Codeine TARGET	Naproxen Sodium Codeine	Istanbul Medeniyet University	marketed	NSAID + opioid combination analgesic	COX-1/COX-2 enzymes; mu opioid receptor
naproxen sodium codein	naproxen sodium codein	Diskapi Yildirim Beyazit Education and Research Hospital	marketed	NSAID + opioid combination analgesic	COX-1, COX-2, mu opioid receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (NSAID + opioid combination analgesic class)

Diskapi Yildirim Beyazit Education and Research Hospital · 1 drug in this class
Istanbul Medeniyet University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Naproxen Sodium Codeine — Competitive Intelligence Brief. https://druglandscape.com/ci/naproxen-sodium-codeine. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab